カテゴリ： MarketLine, スイス, 企業調査

Actelion Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Actelion Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6911
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Actelion Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Actelion Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Actelion Ltd. (Actelion or ‘the company’) is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company classifies its business into single segment, which primarily focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, central nervous system disorders, infectious diseases, cancer, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. Actelion is headquartered in Allschwil, Switzerland.

Scope

- Detailed information on Actelion Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
- Intelligence on Actelion Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Actelion Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Actelion Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Actelion Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Actelion Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Actelion Ltd: Company Overview 9
Actelion Ltd: Overview and Key Facts 9
Actelion Ltd: Overview 9
Actelion Ltd: Key Facts 9
Actelion Ltd: Key Employees 10
Actelion Ltd: Key Employee Biographies 11
Actelion Ltd: Major Products and Services 16
Actelion Ltd: Company History 17
Actelion Ltd: Management Statement 22
Actelion Ltd: Locations and Subsidiaries 24
Actelion Ltd: Key Competitors 25
Actelion Ltd: Company Analysis 26
Actelion Ltd: Business Description 26
Actelion Ltd: SWOT Analysis 28
Actelion Ltd: SWOT Overview 28
Actelion Ltd: Strengths 28
Actelion Ltd: Weaknesses 29
Actelion Ltd: Opportunities 29
Actelion Ltd: Threats 31
Actelion Ltd: Corporate Financial Deals Activity 33
Actelion Ltd: Financial Deals Overview 33
Actelion Ltd: Targets and Partners 35
Actelion Ltd: Top Deals 2014 – 2018YTD* 36
Actelion Ltd: Advisors 37
Actelion Ltd: Top Legal Advisors 37
Actelion Ltd: Top Financial Advisors 37
Actelion Ltd: Partnership 38
Actelion Ltd: Divestments 39
Actelion Ltd: Private Equity and Ownership 40
Actelion Ltd: Recent Developments 41
Actelion Ltd: News and Events Summary 41
Actelion Ltd: Business Expansion 44
Actelion Ltd: Financial Deals 44
Actelion Ltd: Financial Performance 44
Actelion Ltd: Regulatory and Legal Events 45
Actelion Ltd: Research & Development 46
Actelion Ltd: Strategy and Operations 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Actelion Ltd: Key Facts
Table 2: Actelion Ltd: Key Employees
Table 3: Actelion Ltd: Company History
Table 4: Actelion Ltd: Locations and Subsidiaries
Table 5: Actelion Ltd: Key Competitors
Table 6: Actelion Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Actelion Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Actelion Ltd: Targets and Partners
Table 9: Actelion Ltd: Top Deals 2014 - 2018YTD*
Table 10: Actelion Ltd: Legal Advisor Ranking by Value (US$m)
Table 11: Actelion Ltd: Financial Advisor Ranking by Value (US$m)
Table 12: Actelion Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Actelion Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Actelion Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Actelion Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: Actelion Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: Actelion Ltd: News and Events Summary
Table 18: Actelion Ltd: Business Expansion
Table 19: Actelion Ltd: Financial Deals
Table 20: Actelion Ltd: Financial Performance
Table 21: Actelion Ltd: Regulatory and Legal Events
Table 22: Actelion Ltd: Research & Development
Table 23: Actelion Ltd: Strategy and Operations

List of Figures
Figure 1: Actelion Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Actelion Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Actelion Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Actelion Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Actelion Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Actelion Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Actelion Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Actelion Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • International CSRC Investment Holdings Co Ltd (2104)：企業の財務・戦略的SWOT分析
    International CSRC Investment Holdings Co Ltd (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Offshore Oil Engineering Co Ltd (600583)：石油・ガス：M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Bancolombia SA (BCOLOMBIA)：企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Qisda Corporation：戦略・SWOT・企業財務分析
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vestas Wind Systems AS (VWS)：企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Owensboro Municipal Utilities：企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • ITM Power Plc (ITM)-エネルギー分野：企業M&A・提携分析
    Summary ITM Power Plc (ITM Power) is a renewable energy company. It designs and manufactures hydrogen energy systems for clean fuel production and energy storage. The company develops equipment to convert renewable energy to a clean fuel that can be stored for use in transport, industrial, and resid …
  • State Atomic Energy Corporation Rosatom-エネルギー分野：企業M&A・提携分析
    Summary State Atomic Energy Corporation Rosatom (ROSATOM), the Russian Federation national nuclear corporation, is a nuclear company that integrates nuclear companies and R&D institutions which operate in the civilian and defense sectors. It provides a variety of nuclear services that range from ura …
  • China National Petroleum Corporation (CNPC)：戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Black Hills Corporation (BKH)-エネルギー分野：企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Zynerba Pharmaceuticals Inc (ZYNE)：企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • Novartis India Ltd (500672)：企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis), a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • Ocular Therapeutix Inc (OCUL)：企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • M.D.C. Holdings Inc：戦略・SWOT・企業財務分析
    M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tethys Oil AB (TETY)：企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • Sebia SA：医療機器：M&Aディール及び事業提携情報
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Nordstrom, Inc.：企業の戦略・SWOT・財務情報
    Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Enthera Srl：製薬・医療：M&Aディール及び事業提携情報
    Summary Enthera Srl (Enthera), a subsidiary of BiovelocITA Srl, is a biotechnology company, which strives to discover novel medicines for the treatment of diabetes and related gastrointestinal disorders. Gastrointestinal symptoms such as diarrhea and abdominal pain among diabetics are referred to as …
  • Life Time Fitness, Inc：企業の戦略・SWOT・財務情報
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hudson Global Inc (HSON)：企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆